(Q45731952)

English

Inclusion of full length human immunodeficiency virus type 1 (HIV-1) gag sequences in viral recombinants applied to drug susceptibility phenotyping

scientific article published in July 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Inclusion of full length human immunodeficiency virus type 1 (HIV-1) gag sequences in viral recombinants applied to drug susceptibility phenotyping (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

author name string

Laurence H Robinson

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Catherine V Gale

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Jörg-Peter Kleim

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

publication date

1 July 2002

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Journal of Virological Methods

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

104

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

147-160

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900059-9

7 January 2021

based on heuristic

inferred from DOI database lookup

PCR amplification of up to 35-kb DNA with high fidelity and high yield from lambda bacteriophage templates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900059-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900059-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900059-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900059-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of clinical reverse transcriptase sequences on the replication capacity of HIV-1 drug-resistant mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900059-9

7 January 2021

based on heuristic

inferred from DOI database lookup

PCR-mediated recombination: a general method applied to construct chimeric infectious molecular clones of plasma-derived HIV-1 RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900059-9

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900059-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900059-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900059-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900059-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of HIV type 1 protease, reverse transcriptase, cleavage site, and p6 mutations on the virological response to quadruple therapy with saquinavir, ritonavir, and two nucleoside analogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900059-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of resistance to protease inhibitor amprenavir in human immunodeficiency virus type 1-infected patients: selection of four alternative viral protease genotypes and influence of viral susceptibility to coadministered reverse transcriptase n

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900059-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900059-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900059-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900059-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900059-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV type 1 protease cleavage site mutations and viral fitness: implications for drug susceptibility phenotyping assays

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900059-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900059-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0166-0934(02)00059-9

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45731952&oldid=2133803947"